Market insights

Home » Market insights

Merck is Set to Lead Pharmaceutical Licensing Deals in 2018

The pharmaceutical industry is highly volatile, with promising lead candidates making or breaking a company’s year. Companies’ financial success is often down to the strategic deals they are able to make with other pharmaceutical companies and research organisations to enable them to develop the next leading drug in the market, observes GlobalData, a leading data [...]

Melanoma Sales Are Projected to Rise to $5.5 Billion in 2026

The value of the melanoma market was estimated to be $3.3 billion across the seven major markets of France, Germany, Italy, Spain, UK, USA and Australia (7MM) in 2016. This is expected to grow to $5.5 billion in 2026, at a compound annual growth rate (CAGR) of 5.3%, according to GlobalData, a leading data and analytics [...]

Global Glaucoma Market to Reach $3.8 Billion by 2026

The total glaucoma market was estimated to be $2.6 billion across the seven major markets (US, France, Germany, Italy, Spain, UK and Japan) in 2016. This is expected to grow to $3.8 billion in 2026, at a compound annual growth rate (CAGR) of 4.1%, according to GlobalData, a leading data and analytics company. The company’s [...]

NHS Should Consider Expanding Quadrivalent Flu Jab After Fourth Strain Hits Europe

The NHS and other European healthcare providers should start administering quadrivalent vaccines to better protect against the influenza virus according to GlobalData, a leading data and analytics company. In the UK, the NHS recommends that adults receive a jab known as a trivalent flu vaccine, which only protects against three of these four strains. But data suggests [...]

Hospital-Owned Generics Initiative Unlikely to Benefit the CMO Industry

A recently announced plan to establish a not-for-profit generic pharmaceutical company is unlikely to be a boon to the contract manufacturing organisation (CMO) industry, according to GlobalData, a leading data and analytics company. A consortium of five hospital organisations representing 450 hospitals aims to address the problem of needed medications that are in short supply or [...]

Japanese Pharma: No Longer “Lost in Translation”

A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increased internationalisation. The CPhI Japan 2018 report – released ahead of what is likely to be the largest ever CPhI Japan (18-20 April) – has identified that demographic pressures on healthcare costs are driving [...]

Cell Line Development Market (2017-2022): Rapid Growth in Pharma Industry Key to Growth

The "Cell Line Development Market: By Product, By Source, By Type, By Application, & By Region - Forecast (2017- 2022)" report has been added to Research and Markets' offering. Cell line construction or cell line development acts as a key factor in reducing the production costs of biopharmaceuticals while producing a high yield of product. [...]

Expectations for 2018: Making Britain’s Manufacturing Smarter

First came the dawn of mechanical machines, succeeded by the introduction of electricity, quickly followed by the third industrial era, the advent of computers and the Internet. Now, as we enter the so-called fourth industrial revolution, Industry 4.0 is moving from buzzword to reality. In this article, Martyn Williams, Managing Director of industrial software provider, COPA-DATA UK, [...]

Major Changes for Bio Supply Forecast in 2018 by bioLIVE

Industry experts from bioLIVE – the new UBM biomanufacturing and bioprocessing event taking place next year in Madrid (9-11 October) – predict that 2018 will usher in a new age of increased integration and collaboration across the large and small molecule supply chain. Additionally, next year will also see a continued rise in the European bioprocessing and [...]

Positive Leadership is Needed to Improve Healthcare Safety

There are serious concerns around medication error internationally, and a newly completed international study has identified positive leadership and increasing engagement as being key to improving matters. Professor Derek Stewart, from Robert Gordon University’s (RGU) School of Pharmacy and Life Sciences has recently presented these findings from an international study into medication error and safety, which was funded [...]